CIK 0001267565
- Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- Phone
- +1 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-03-17 | Brannelly Paul Executive Vice President & CFO | Shares withheld for taxes | −388 | $14.95 | $6K | 100,227 |
| 2017-03-17 | Duke Barry S See remarks | Shares withheld for taxes | −388 | $14.95 | $6K | 20,087 |
| 2017-03-17 | Fleming Alison B Chief Technology Officer | Shares withheld for taxes | −388 | $14.95 | $6K | 24,313 |
| 2017-02-10 | Fleming Alison B Chief Technology Officer | Grant or award | +16,250 | 24,701 | ||
| 2017-02-10 | Fleming Alison B Chief Technology Officer | Grant or award · Stock Option (Right to Purchase) | +32,500 | 32,500 | ||
| 2017-02-10 | Heffernan Michael Thomas Chairman, President and CEO | Grant or award | +55,000 | 610,555 | ||
| 2017-02-10 | Heffernan Michael Thomas Chairman, President and CEO | Grant or award · Stock Option (Right to Purchase) | +110,000 | 110,000 | ||
| 2017-02-10 | Duke Barry S See remarks | Grant or award | +13,750 | 20,475 | ||
| 2017-02-10 | Duke Barry S See remarks | Grant or award · Stock Option (Right to Purchase) | +27,500 | 27,500 | ||
| 2017-02-10 | Brannelly Paul Executive Vice President & CFO | Grant or award | +16,250 | 100,615 | ||
| 2017-02-10 | Brannelly Paul Executive Vice President & CFO | Grant or award · Stock Option (Right to Purchase) | +32,500 | 32,500 | ||
| 2017-01-31 | Heffernan Michael Thomas Chairman, President and CEO | Option exercise | +3,013 | $0.48 | $1K | 555,555 |
| 2017-01-31 | Heffernan Michael Thomas Chairman, President and CEO | Option exercise · Stock Option (Right to Purchase) | −3,013 | 0 | ||
| 2017-01-27 | Fleming Alison B Chief Technology Officer | Grant or award | +1,240 | $10.08 | $12K | 8,451 |
| 2017-01-27 | Duke Barry S See remarks | Grant or award | +834 | $10.08 | $8K | 6,725 |
| 2017-01-27 | Brannelly Paul Executive Vice President & CFO | Grant or award | +1,006 | $10.08 | $10K | 84,365 |
| 2017-01-27 | Heffernan Michael Thomas Chairman, President and CEO | Grant or award | +1,239 | $10.08 | $12K | 552,542 |
| 2016-08-12 | Fallon John A. Director | Purchase | +2,375 | $10.59 | $25K | 2,375 |
| 2016-07-29 | Heffernan Michael Thomas Chairman, President and CEO | Grant or award | +1,212 | $10.31 | $12K | 551,303 |
| 2016-07-29 | Brannelly Paul Executive Vice President & CFO | Grant or award | +983 | $10.31 | $10K | 83,359 |
Page 36 of 41 · 811 trades